Immunocytokines for cancer treatment: past, present and future

by Neri, Dario, Sondel, Paul M.
Published in Curr Opin Immunol (2016)

Advances in Anti-GD2 Immunotherapy for Treatment of High-Risk Neuroblastoma

by Voeller, Julie, Sondel, Paul M.
Published in J Pediatr Hematol Oncol (2019)

Anti-GD2 Strategy in the Treatment of Neuroblastoma

by Yang, Richard K., Sondel, Paul M.
Published 2010

Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity

by Alderson, Kory L., Sondel, Paul M.
Published 2011

Current and Potential Uses of Immunocytokines as Cancer Immunotherapy

by Sondel, Paul M., Gillies, Stephen D.
Published 2012

Enhancing Cancer Immunotherapy Via Activation of Innate Immunity

by Goldberg, Jacob L., Sondel, Paul M.
Published in Semin Oncol (2015)

Pleasant memories: remembering immune protection while forgetting about graft-versus-host disease

by Sondel, Paul M., Buhtoiarov, Ilia N., DeSantes, Kenneth
Published 2003

RESPONSIVENESS OF GERMFREE MICE IN MIXED LEUKOCYTE CULTURE : REEXAMINING THE NATURE OF THE RESPONDING UNIT

by Widmer, Michael B., Sondel, Paul M., Bach, Fritz H.
Published 1972

T-cell-independent Antitumor Effects of CD40 Ligation

by Rakhmilevich, Alexander L., Alderson, Kory L., Sondel, Paul M.
Published 2012

Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy

by Perez Horta, Zulmarie, Goldberg, Jacob L, Sondel, Paul M
Published in Immunotherapy (2016)

Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides

by Buhtoiarov, Ilia N, Sondel, Paul M, Eickhoff, Jens C, Rakhmilevich, Alexander L
Published 2007

Immunotherapy for Pediatric Cancer

by Grupp, Stephan A., Verneris, Michael, Sondel, Paul M., Cooper, Laurence J. N.
Published 2008

The development of antibody –based immunotherapy with (EMD-273063) Hu14.18-IL2 in melanoma and neuroblastoma

by Yamane, Brett H., Hank, Jacquelyn A., Albertini, Mark R., Sondel, Paul M.
Published 2009

Synergy of anti-CD40, CpG and MPL in activation of mouse macrophages

by Shi, Yongyu, Felder, Mildred A.R., Sondel, Paul M., Rakhmilevich, Alexander L.
Published in Mol Immunol (2015)

Immunotherapy in pediatric malignancies: current status and future perspectives

by Capitini, Christian M., Otto, Mario, DeSantes, Kenneth B., Sondel, Paul M.
Published in Future Oncol (2014)

Intravital Metabolic Autofluorescence Imaging Captures Macrophage Heterogeneity Across Normal and Cancerous Tissue

by Heaster, Tiffany M., Heaton, Alexa R., Sondel, Paul M., Skala, Melissa C.
Published in Front Bioeng Biotechnol (2021)

Up-regulation of Fas (CD95) expression in tumour cells in vivo

by Peshes-Yaloz, Naama, Rosen, Dalia, Sondel, Paul M, Krammer, Peter H, Berke, Gideon
Published 2007

NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy

by Wang, Wei, Erbe, Amy K., Hank, Jacquelyn A., Morris, Zachary S., Sondel, Paul M.
Published in Front Immunol (2015)

Genotyping Single Nucleotide Polymorphisms (SNPs) and Copy Number Variability (CNV) of the FCGRs (FCGR3A and FCGR2C) expressed on NK cells

by Erbe, Amy K., Wang, Wei, Gallenberger, Mikayla, Hank, Jacquelyn A., Sondel, Paul M.
Published in Methods Mol Biol (2016)

Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-carbohydrate Antibodies to Tumor Cells

by Sheridan, Rachael T. C., Hudon, Jonathan, Hank, Jacquelyn A., Sondel, Paul M., Kiessling, Laura L.
Published 2014